Two Sigma Investments, LP Xenon Pharmaceuticals Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 243,579 shares of XENE stock, worth $9.33 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

243,579

Previous 195,129 24.83%

Holding current value

$9.33 Million

Previous $7.61 Million 25.97%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$36.12 - $43.96 $1.75 Million - $2.13 Million	48,450 Added 24.83%	243,579 $9.58 Million
Q2 2024 Aug 14, 2024	SELL	$36.25 - $43.75 $2.88 Million - $3.48 Million	-79,497 Reduced 28.95%	195,129 $7.61 Million
Q1 2024 May 15, 2024	SELL	$42.66 - $50.04 $2.79 Million - $3.27 Million	-65,389 Reduced 19.23%	274,626 $11.8 Million
Q4 2023 Feb 14, 2024	BUY	$28.7 - $46.46 $7.44 Million - $12.1 Million	259,382 Added 321.68%	340,015 $15.7 Million
Q3 2023 Nov 14, 2023	BUY	$34.16 - $39.73 $2.12 Million - $2.46 Million	62,000 Added 332.74%	80,633 $2.75 Million
Q2 2023 Aug 14, 2023	BUY	$34.84 - $43.54 $250,116 - $312,573	7,179 Added 62.68%	18,633 $717,000
Q1 2023 May 15, 2023	BUY	$33.46 - $40.35 $383,250 - $462,168	11,454 New	11,454 $409,000
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $1.72 Million - $2.23 Million	55,974 New	55,974 $2.02 Million
Q2 2022 Aug 15, 2022	SELL	$25.44 - $35.16 $5.92 Million - $8.18 Million	-232,650 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$25.09 - $33.13 $1.15 Million - $1.51 Million	-45,693 Reduced 16.42%	232,650 $7.11 Million
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $1.7 Million - $3.85 Million	108,667 Added 64.04%	278,343 $8.7 Million
Q3 2021 Nov 15, 2021	BUY	$14.86 - $19.45 $1.26 Million - $1.64 Million	84,458 Added 99.11%	169,676 $2.59 Million
Q2 2021 Aug 16, 2021	BUY	$16.81 - $20.0 $143,086 - $170,240	8,512 Added 11.1%	85,218 $1.59 Million
Q1 2021 May 17, 2021	BUY	$13.65 - $21.31 $356,879 - $557,149	26,145 Added 51.71%	76,706 $1.37 Million
Q4 2020 Feb 16, 2021	BUY	$9.49 - $16.04 $5,466 - $9,239	576 Added 1.15%	50,561 $778,000
Q3 2020 Nov 16, 2020	SELL	$10.82 - $13.35 $758,806 - $936,235	-70,130 Reduced 58.39%	49,985 $553,000
Q2 2020 Aug 14, 2020	BUY	$10.21 - $14.9 $321,717 - $469,499	31,510 Added 35.56%	120,115 $1.51 Million
Q1 2020 May 15, 2020	BUY	$8.08 - $17.57 $95,247 - $207,115	11,788 Added 15.35%	88,605 $1.01 Million
Q4 2019 Feb 14, 2020	BUY	$8.11 - $14.65 $622,985 - $1.13 Million	76,817 New	76,817 $1.01 Million
Q2 2019 Aug 14, 2019	SELL	$8.51 - $10.75 $494,847 - $625,101	-58,149 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$6.39 - $10.42 $908,095 - $1.48 Million	-142,112 Reduced 70.96%	58,149 $591,000
Q4 2018 Feb 14, 2019	BUY	$5.61 - $12.62 $693,822 - $1.56 Million	123,676 Added 161.49%	200,261 $1.26 Million
Q3 2018 Nov 14, 2018	BUY	$9.0 - $14.9 $689,265 - $1.14 Million	76,585 New	76,585 $1.01 Million

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Xenon Pharmaceuticals Inc. Transaction History